Largest biotech companies in the United States by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Amgen leads the 20 biotech companies in the United States ranked by total liabilities, at HUF 27.87T, ahead of Gilead Sciences (HUF 12.38T) and Biogen (HUF 3.8T). Figures as of 20 Nov 2026, 18:58 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 20
- First
- AmgenHUF 27.87T
- Median
- HUF 197.6B
- Combined market value
- HUF 250T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Biotech▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | HUF 27.87T | HUF 80.75T | HUF 149,292.55 | 0.60% up | 30% up | ||
| 2 | Gilead SciencesGILD · Health Care | HUF 12.38T | HUF 71.15T | HUF 57,364.61 | 1.27% up | 31% up | ||
| 3 | BiogenBIIB · Health Care | HUF 3.8T | HUF 12.58T | HUF 85,120.04 | 1.26% up | 41% up | ||
| 4 | ModernaMRNA · Health Care | HUF 1.25T | HUF 27T | HUF 66,721.86 | 1.59% down | 740% up | ||
| 5 | Halozyme TherapeuticsHALO · Health Care | HUF 842.4B | HUF 3.6T | HUF 31,607.51 | 0.12% down | 32% up | ||
| 6 | Neurocrine BiosciencesNBIX · Health Care | HUF 468.8B | HUF 5.28T | HUF 52,158.77 | 2.07% down | 10% up | ||
| 7 | ImmunityBioIBRX · Health Care | HUF 340.6B | HUF 2.21T | HUF 2,074.85 | 7.15% down | 216% up | ||
| 8 | RepligenRGEN · Health Care | HUF 286.9B | HUF 3.61T | HUF 56,546.57 | 2.38% down | 5% up | ||
| 9 | Revolution MedicinesRVMD · Health Care | HUF 246B | HUF 11.98T | HUF 55,396.90 | 2.15% up | 125% up | ||
| 10 | ExelixisEXEL · Health Care | HUF 232.4B | HUF 5.44T | HUF 22,301.28 | 0.40% down | 55% up | ||
| 11 | Bio-TechneTECH · Health Care | HUF 162.8B | HUF 3.89T | HUF 24,734.98 | 0.03% up | 18% up | ||
| 12 | VaxcytePCVX · Health Care | HUF 107.9B | HUF 3.04T | HUF 19,202.60 | 3.26% down | 22% up | ||
| 13 | Adaptive BiotechnologiesADPT · Health Care | HUF 97.9B | HUF 1.54T | HUF 9,520.52 | 0.21% down | 51% up | ||
| 14 | Kodiak SciencesKOD · Health Care | HUF 66B | HUF 2.19T | HUF 33,503.79 | 0.61% up | 371% up | ||
| 15 | Twist BioscienceTWST · Health Care | HUF 57.5B | HUF 2.44T | HUF 35,718.10 | 5.92% down | 291% up | ||
| 16 | Kymera TherapeuticsKYMR · Health Care | HUF 55.5B | HUF 3.36T | HUF 39,328.69 | 3.15% down | 81% up | ||
| 17 | Scholar Rock HoldingSRRK · Health Care | HUF 54B | HUF 2.04T | HUF 16,690.67 | 2.58% down | 25% up | ||
| 18 | Krystal BiotechKRYS · Health Care | HUF 38.9B | HUF 3.17T | HUF 106,831.17 | 0.55% down | 49% up | ||
| 19 | ImmunovantIMVT · Health Care | HUF 35.5B | HUF 2.26T | HUF 10,918.49 | 1.29% down | 44% up | ||
| 20 | CG OncologyCGON · Health Care | HUF 13.3B | HUF 2.47T | HUF 27,690.80 | 0.60% down | 93% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 340.1 HUF).
Questions and answers
Which biotech companies in the United States rank first by total liabilities?
Amgen (HUF 27.87T), Gilead Sciences (HUF 12.38T) and Biogen (HUF 3.8T) are the top three of the 20 biotech companies in the United States ranked by total liabilities as of 20 Nov 2026, 18:58 UTC.
How many biotech companies in the United States are in this ranking?
20 are ranked by total liabilities.
What are these biotech companies in the United States worth together?
The 20 biotech companies in the United States ranked by total liabilities have a combined market value of HUF 250T as of 20 Nov 2026, 18:58 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech companies in the United States by total liabilities”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.